To identify potential molecular mechanism of miR-145 in pancreatic adenocarcinoma development and treatment resistance, we determined whether miR-145 inhibited cell migration and cell viability under gemcitabine treatment though p70S6K1. This evidence concerns the gene RPS6KB1 and pancreatic adenocarcinoma.